Bio-Techne Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
37.73 M |
Public Float |
36.87 M |
Bio-Techne Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.11 |
Market Cap |
$8.14 B |
Shares Outstanding |
37.87 M |
Public Float |
37.26 M |
Address |
614 McKinley Place NE Minneapolis Minnesota 55413 United States |
Employees | - |
Website | http://www.bio-techne.com |
Updated | 07/08/2019 |
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. |